Singulex, Inc., is a leader in advanced biomarker research, deploying high precision, high sensitivity, digital immunoassay technology to enable groundbreaking discovery, innovate therapies and improved healthcare.
The Erenna® Immunoassay System, powered by Singulex's patented single-molecule detection technology, accurately, precisely and reliably quantifies low-abundance biomarkers at or below sub-picogram concentrations – even in healthy individuals. This unique high-definition technology enhances the clinical utility of biomarkers and allows researchers to gain insights into drug safety and efficacy.
- Quantifying the Previously Undetectable
- Uncovering Novel Biology
- Accelerating Discovery
- Generating Relevant Data
- Requiring Fewer Data Points for Critical Decision Making
- Reducing Program Costs & Improving ROI
The Erenna Immunoassay System includes fully equipped instrumentation, integrated and prepared reagents for high-precision, ultrasensitive immunoassays, and dedicated Sgx link™ software to automatically analyze data and display detailed assay reports.
The Singulex Solution is flexible to meet your needs and includes the Erenna Immunoassay System, High-Definition Immunoassays and a full range of Custom Services; Sample Testing, Assay Development and Antibody Derivatization Services; to accelerate your clinical trials & therapeutics management, and translational life science research.
Unless otherwise noted, Singulex products are for research use only and not intended for diagnostics use.
Contact for More Information.